Virginia Cancer Specialists, PC, Arlington
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg
Virginia Cancer Specialists, PC, Fairfax
a 12 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07222800

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Next Oncology Virginia Cancer Specialist, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT07629960

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

University of Virginia Medical Center, Charlottesville
Mary Washington Healthcare, Fredericksburg
Hematology Oncology Associates of Fredericksburg Admin, Fredericksburg
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT07284849

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

University of Virginia Health, Charlottesville
Bon Secours St. Francis Medical Center, Midlothian
Virginia Commonwealth University - Massey, Richmond

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07058012

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Kaiser Permanente-Burke Medical Center, Burke
Kaiser Permanente Tysons Corner Medical Center, McLean
VCU Massey Cancer Center at Stony Point, Richmond
a 3 ďalších

Prebieha nábor

Vek 45 až 70 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05080673

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Kaiser Permanente-Burke Medical Center, Burke
Cancer Specialists of Tidewater Limited, Chesapeake
Peninsula Cancer Institute-Gloucester, Gloucester
a 15 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT05174169

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

NEXT Oncology, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT07321106

Shield Post-Approval Study Protocol

Tidewater Physician Multispecialty Group Clinical Research, Williamsburg

Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov

Vek 45 až 81 · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06880055

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NEXT Virginia, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT07458347

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Virginia Oncology Associates, Norfolk
Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA), Salem

Prebieha náborFáza 2

Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 6. 2026 · NCT07011576

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Research Site, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

NEXT Oncology Virginia, Fairfax

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 6. 2026 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Next Oncology Virginia, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 5. 2026 · NCT05379985

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

NEXT, Virginia, Fairfax

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 2. 2026 · NCT07145255

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

GSK Investigational Site, Richmond

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 1. 2026 · NCT05855200

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Charlottesville

Prebieha náborObservačná štúdia

Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.